The Latest in Lung Cancer

Oncology Practice

Frontline veliparib/cisplatin/etoposide shows efficacy in advanced SCLC

December 19, 2018

Lung Cancer

Oncology Practice

ICYMI: Durvalumab boosts overall survival in stage III NSCLC

December 10, 2018

Lung Cancer

Oncology Practice

Perioperative M&M similar for lobar, sublobar surgeries in early lung cancer

December 7, 2018

Lung Cancer

Oncology Practice

Atezolizumab combination regimen approved for advanced non-squamous NSCLC

December 7, 2018

Lung Cancer

The Journal of Community and Supportive Oncology

Trio of biosimilars have good showing

December 6, 2018

The Journal of Community and Supportive Oncology

Paradigm-changing osimertinib approval in front-line for advanced NSCLC

December 6, 2018

Lung Cancer

The Journal of Community and Supportive Oncology

Symptom burdens related to chemotherapy-induced anemia in stage IV cancer

December 5, 2018

Oncology Practice

A novel tracer shows promise for detecting CD8 T-cells in advanced solid tumors

November 30, 2018

Oncology Practice

Lenvatinib/Pembrolizumab shows promise in previously treated metastatic NSCLC

November 20, 2018

Oncology Practice

TMB measured by NGS may ID SCLC patients who will benefit from immunotherapy

November 20, 2018

Oncology Practice

Immunotherapy-related toxicities may be more common than reported in trials

November 19, 2018

Oncology Practice

Early phase 2 data: Mocetinostat/durvalumab combo shows promise in mNSCLC

November 14, 2018

Oncology Practice

Capmatinib active against NSCLC with MET exon 14 mutations

November 9, 2018

Lung Cancer

Oncology Practice

Cigarette smoking at lowest level ever

November 8, 2018

Oncology Practice

FDA approves lorlatinib as second line for ALK-positive advanced NSCLC

November 5, 2018

Lung Cancer